BIM
Bogle Investment Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,731
| Closed | -$334K | – | 37 |
|
|
2020
Q4 | $334K | Sell |
3,731
-11,363
| -75% | -$1.02M | 0.53% | 103 |
|
|
2020
Q3 | $1.56M | Buy |
15,094
+494
| +3% | +$51.1K | 0.46% | 95 |
|
|
2020
Q2 | $1.16M | Buy |
+14,600
| New | +$1.16M | 0.19% | 157 |
|
|
2018
Q3 | – | Sell |
-82,616
| Closed | -$4.17M | – | 284 |
|
|
2018
Q2 | $4.17M | Sell |
82,616
-54,022
| -40% | -$2.73M | 0.3% | 108 |
|
|
2018
Q1 | $7.19M | Buy |
+136,638
| New | +$7.19M | 0.54% | 76 |
|
|
2017
Q2 | – | Sell |
-39,951
| Closed | -$1.16M | – | 320 |
|
|
2017
Q1 | $1.16M | Buy |
+39,951
| New | +$1.16M | 0.08% | 210 |
|
|
2016
Q4 | – | Sell |
-162,870
| Closed | -$5.14M | – | 347 |
|
|
2016
Q3 | $5.14M | Sell |
162,870
-124,896
| -43% | -$3.94M | 0.37% | 94 |
|
|
2016
Q2 | $8.09M | Buy |
+287,766
| New | +$8.09M | 0.56% | 66 |
|
|
2016
Q1 | – | Sell |
-49,842
| Closed | -$1.99M | – | 402 |
|
|
2015
Q4 | $1.99M | Buy |
+49,842
| New | +$1.99M | 0.14% | 189 |
|
|
2014
Q2 | – | Sell |
-193,383
| Closed | -$4.89M | – | 345 |
|
|
2014
Q1 | $4.89M | Buy |
+193,383
| New | +$4.89M | 0.34% | 106 |
|